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Abstract
Pre-analytical steps contribute to an overall quality of the results of laboratory
trials. The volume of blood drawn into the blood-collection tube and the anticoag-
ulant amount introduced into the tube during its production should ensure the
anticoagulant level in the recommended range; otherwise, the results can be altered.
In evacuated blood-collection tubes, the internal under-pressure at the instant of
the blood specimen collection affects the draw volume. During the shelf life, the
internal under-pressure deteriorates. With no testing procedures in place, inappro-
priate anticoagulant levels can pass unnoticed. The chapter details testing proce-
dures ensuring that the tubes are used only if, and only until, they are of the
adequate quality. The reasoning behind the methodology is fully explained, and the
case studies of the quality evaluations are discussed.
Keywords: evacuated blood-collection tubes, K3EDTA, K2EDTA, citrate, quality
evaluation, draw-volume measurement, anticoagulant concentration
1. Introduction
Evacuated blood-collection tubes are evacuated containers intended for a venous
blood specimen collection. They consist of a tube and a closure, which has to be
tight to restrain low pressure—vacuum inside the tubes during their shelf life—but,
on the other hand, it also has to be soft enough to let a sharp end of a blood-
collection device to penetrate into a tube. The collection device has a disposable
needle attached to the other side for phlebotomy.
Evacuated blood-collection tubes improved patients’ and medical personnel’s
safety and mostly replaced classical tubes, which required a syringe and a needle for
a specimen collection. In a continuation, wherever a tube is mentioned, the evacu-
ated blood-collection tube is meant.
To prevent blood coagulation, tubes contain anticoagulants, either as dry sub-
stances attached to the internal walls or as solutions. Widely known and used are
sodium citrate and salts of ethylenediaminetetraacetic acid (EDTA), usually present
either as dipotassium or tripotassium salts, K2EDTA or K3EDTA.
Other substances, additives might be introduced as well to ensure the adequate
properties or behavior of the tubes’ internal walls or closures; nevertheless, they are
expected not to interfere with a determination and affect analytical results. A
noncompliant constituent detected in citrate tubes was magnesium which leached
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from a stopper and was consequently influencing the prothrombin time (PT) results
[1]. A comprehensive study evaluating different tubes comprising also recently
introduced low-magnesium version confirmed that the PT and INR differences
between the tubes are correlated with the magnesium concentration differences [2].
Manufacturers are obliged to specify on the label of a tube: a type of anticoagu-
lant, a nominal draw volume, a lot number, and expiration date; within this text, we
use a term expiry date as well.
Anticoagulant concentration in a blood sample after specimen collection should
be within an appropriate range; otherwise, analytical results might be altered. To
reach this objective, an accurate amount of anticoagulant should be introduced into
a tube during production, and a draw at the moment of a specimen collection
should be adequate to ensure a volume of blood entering a tube is within an
acceptable range. A label on a tube provides guidance for inspection if the volume is
within the suggested limits; however, this is only true if the label is precisely and
accurately positioned.
The latest version of the GP39-A6 standard of the CLSI standardization body
(Clinical and Laboratory Standards Institute) [3] requires of the tubes’ manufac-
turers to ensure that until expiration date, the anticoagulant concentration remains
within the 5% range of the value stated on a label. A draw volume is considered
acceptable if it does not differ from the stated nominal volume for more than10%.
The standard GP34-A recognizes the importance of appropriate blood-to-EDTA
ratio for obtaining optimal examination results but avoids stating the exact limits.
The EDTA can, if in a concentration which is too high hypertonically shrink red
cells, affect red cell size and cause morphological changes. On the other hand, it can
too extensively chelate calcium and other cations such as magnesium and zinc and
affect the activity of alkaline phosphatase enzyme label used in chemiluminescent
assays or reduce the efficiency of the recognition of proteins by antibodies due to
the proteins’ conformation changes [4].
The predecessor of CLSI, the National Committee for Clinical Laboratory Stan-
dards (NCLLS), was in the H1-A5 standard more explicit in terms of some antico-
agulants’ concentrations [5]. It explains that only a little bit less than a half
(1.15 mmol/L) out of the total calcium concentration (2.5 mmol/L) corresponds to
unbound calcium that needs to be chelated stoichiometrically with EDTA to prevent
coagulation. For that reason, it suggests that EDTA concentration in blood should be
between 3.7 and 5.4 mmol/L, since excessive concentration causes morphological
changes in the blood.
Not consistent with this requirement was DIN ISO 6710: 1996-12 standard
requiring the EDTA concentration within the 4.11–6.843 mmol/L range [6].
A potential user can during time come across the tubes which were
produced by not having the same set of requirements on the mind. As we already
previously demonstrated, the tubes if evaluated as such not yet in contact with a
blood sample are not all the same, and change in their own characteristics
during their shelf life and the testing procedure which we suggested are easy to
perform [7].
A concise review reflects on the behavior of EDTA as an anticoagulant in hema-
tology and furthermore discusses its usage in proteomics, general clinical chemistry,
and its applicability for measuring cytokines, protein, peptides, and cardiac markers
[8]. Elsewhere, influences of a form of EDTA and its concentration on the results of
hematological tests were profoundly discussed in relation to spurious counts and
results regarding platelets [9], white blood cells, red blood cells, hemoglobin, red
cell indices, and reticulocytes [10]; under-filled or over-filled evacuated tubes
changing the anticoagulant level in a sample are exposed as an influential pre-
analytical source of errors.
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For citrate tubes the DIN ISO 6710: 1996-12 standard recommends trisodium
citrate solutions with concentrations between 100 and 136 mmol/L; however, the
H1-A5 standard specifies the concentrations 105, 109, and 129 mmol/L.
Due to all these differences, the GP39-A6 standard omitted all the anticoagulant
concentrations’ details, leaving it entirely to a producer to bear the responsibility for
securing appropriate concentration, fulfilling all the requirements, and demon-
strating that they are actually met, or in other words verifying that the tubes are
actually fit for purpose.
The GP34-A standard provides guidance for validation and verification of tubes
for venous and capillary blood specimen collection [4]. Both a manufacturer and a
clinical laboratory are required to perform a comparability study on blood samples
for two or more sets of tubes comprising a set which was already evaluated and
approved previously. A manufacturer performs such a test after a new product was
developed or where any correction actions are necessary for the production process.
The laboratory needs to do it when switching from one product to another or when
changing a vendor.
A within-tube precision study requires a minimum of 20 subjects, and each
sample needs to be analyzed in replicates; an appropriate number of samples,
evenly distributed through the analytical measurement, are essential for trueness
evaluation [4]. Several studies with sometimes dissimilar outcomes can be found in
the literature.
Two blood-collection devices either with an aligned [Becton Dickinson (BD)] or
at an angle needle holder (Greiner Labortechnik GmbH) were evaluated either
enabling a direct linear (BD) or interrupted nonlinear blood flow. A mechanical
strain on blood cells was recognized as a factor potentially causing the efflux of
intracellular constituents into the serum in an interrupted nonlinear flow. The
magnesium, plasma hemoglobin, and prothrombin time within-subject variations
were confirmed in 55 healthy individuals using a Student paired t-test. A difference
in a tube material either glass or polymer was also recognized as a likely contribut-
ing factor [11].
Nevertheless, contrasting outcomes were obtained for prothrombin time deter-
minations in the glass and PVC tubes with two distinct citrate concentrations where
neither material caused the significantly different results [12]. Yet another study,
establishing a protocol for comparing the citrate evacuation blood-collection tubes
with glass tubes employing eight measuring systems, confirmed a statistically sig-
nificant but clinically not relevant difference in prothrombin time results, which
were more pronounced with the tubes of the lowest 2.7 mL draw volume [13].
Differences in some parameters were confirmed if BD plastic citrate tubes were
used instead of glass tubes, but they were considered unlikely to be clinically
significant [14], though a comprehensiveness of a study was challenged arguing
that only healthy volunteers were involved and by these means it was not yet
proven that glass tubes are interchangeable with the plastic tubes [15]. But a study
performed on Greiner glass citrate and plastic tubes confirmed that the tubes are
substitutable as far as either untreated or patients on a traditional oral anticoagulant
therapy are concerned and that this applies for the whole shelf life of the tubes [16].
Nevertheless, the plastic tubes of different brands evaluated on patients and
healthy volunteers were confirmed to be statistically but not clinically significantly
different [17]. For patients on oral anticoagulant therapy with vitamin K antago-
nists, ANOVA test confirmed statistically significant differences in prothrombin
time for the tubes of four different types [18]. The study supports the claim that
validation is always necessary when there is a change in a tube type.
A research performed on a group of individuals evaluating the effect of under-
filled EDTA tubes on hematological parameters by employing a particular type of
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analyzer [19] leads to contrasting outcomes not necessarily aligned with other
studies [20] and general principles and recommendations.
Validations and verifications as required by the standard GP34-A are complex to
perform, time demanding, and require resourceful personnel [4].
The standard exposes a blood collection as a pre-analytical (preexamination)
source causing varying degrees of errors. It brings to light a lack of a mechanism
that would enable systematic evaluations of the influences of pre-analytical
(preexamination) variables on laboratory test (examination) results [4].
The characteristics of the tubes entering the pre-analytical phase are such vari-
ables, and this is where this chapter tends to contribute.
Differences between tubes of different brands examined 5 years apart in time
are going to be enlightened, and the testing procedures which are fast, cheap, and
easy to implement into laboratory practice are explained in full details. Robustness
of personal profiles of athletes and validation studies performed on blood samples
can profit from knowing the attributes of the tubes that were actually used or
evaluated.
2. Quality of evacuated blood-collection tubes for hematological tests
reevaluated in 5 years’ time
In this section, we compare the results of a quality evaluation of the blood-
collection tubes, on which we previously reported [7], with the results obtained in
5 years’ time. The same producers were considered, namely, Becton Dickinson,
Greiner Bio-One, and Laboratorijska tehnika Burnik d. o. o.
Figures 1–4 are dedicated to the tubes of four different brands. The abscise axis
stands for a draw volume. Ordinate on the right indicates an anticoagulant concen-
tration expected for a blood sample after a specimen collection. We are going to
explain the meaning of the left ordinate axis, which relates to a testing procedure,
later. A frame in green indicates the limits set by the H1-A5 standard [5]. The
horizontal lines confine the range of the acceptable anticoagulant concentration; the
left vertical line represents a limit under which a draw volume is expected not to fall
to prevent the anticoagulant concentration to rising too high.
We kept the assigned marks A, B, and C from the previous study for the
K3EDTA tubes, and D for the K2EDTA tubes, not disclosing the producers’ identity.
We additionally included the tubes F, not previously evaluated. The more recent
Figure 1.
Anticoagulant concentrations and draw volumes of the A brand tubes obtained 5 years apart in time (orange/
blue) and of the tubes F not previously included (the numbers in the labels indicate time until the expiration).
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Figure 2.
Anticoagulant concentrations and draw volumes of the B brand tubes obtained 5 years apart in time (orange/
blue); the numbers in the labels indicate the time until the expiration.
Figure 3.
Anticoagulant concentrations and draw volumes of the C brand tubes obtained 5 years apart in time (orange/
blue); the numbers in the labels indicate the time until the expiration.
Figure 4.
Anticoagulant concentrations and draw volumes of the D brand tubes obtained 5 years apart in time (orange/
blue); the numbers in the labels indicate the time until the expiration.
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results are marked with an asterisk; a number indicates the number of days until the
expiration.
Ellipses in Figures 1–4 provide an insight into a spread of results obtained for
the tubes within a series of measurements. Ellipses in blue correspond to the more
recent results; those in orange originate from a previous study. A length of a
horizontal axis of an ellipse equals a standard deviation of the draw-volume mea-
surements; a vertical axis indicates a standard deviation of the anticoagulant con-
centration as expected for blood samples. A crossing of the two axes of an ellipse is
defined by the mean values of the two parameters. The smaller the ellipse, the
higher the quality of the produced tubes in terms of their precision or, in other
words, a repeatability of a product.
2.1 K3EDTA tubes
From this point of view, the A brand tubes were and remain of a high quality. In
spite of having a very long expiration date, unless very close to the expiration
(A*18), the draw volumes generally remain adequate; however, the anticoagulant
concentration is too high and not in the accordance with the higher limit set by the
H1-A5 standard [5]. All the ellipses of the A brand tubes are above the green
rectangle in Figure 1. The same is true for the tubes F, which are of the same
manufacturer. This example demonstrates that an adequate draw volume does not
yet ensure the adequate anticoagulant concentration as far as the H1-A5 is
concerned. The tubes were obviously produced following an older DIN ISO 6710:
1996-12 standard, for which the anticoagulant concentration 6.843 mmol/L was still
acceptable. With this limit in mind, only the A*18A anticoagulant concentration
would be excessive. The characteristics of these tubes clearly contrast those of the
tubes B and C, as the figures in the continuation demonstrate.
In the B brand tubes (Figure 2), an improvement in the overall quality of the
results is evident in 5 years’ time. Previously the ellipses were much larger, and they
exceeded the upper anticoagulant concentration limit even with the draw volumes
very close to the nominal 3 mL mark. The ellipses in blue are small and remain
within the green rectangle during the whole shelf life; nevertheless it has to be
mentioned the shelf life was at the time of purchase much shorter than in the A
brand tubes.
The C brand tubes exhibit a good repeatability of the product; however, the
anticoagulant concentration starts exceeding slightly the higher-anticoagulant con-
centration limit already with the draw volumes approaching 2.8 mL, proving that
the draw volume within the acceptable range does not yet guarantee the correct
anticoagulant concentration.
2.2 K2EDTA tubes
The product repeatability of the D brand tubes is good, but the anticoagulant
concentration starts exceeding the upper limit already approximately 200 days
before the expiration date and with the draw volumes falling below 2.9 mL what is
far above the acceptable lower limit.
This study confirmed that a control of a draw volume is not the main quality
issue and does not ensure that the anticoagulant concentration is adequate. Only in
four cases, the draw volumes below the 2.7 mL limit were observed, and this only
happened when the tubes were tested closer than 20 days before their expiration
date. On the other hand, in more than 20 cases, the anticoagulant concentration
limit as set by the H1-A5 standard was exceeded at the draw volumes in the
recommended range.
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It also needs to be mentioned that if the draw-volume inspection relays on the
label mark a judgment can be false. During our first study, we found out that only
one brand of the tubes had a label positioned precisely; in all others the indicators
on the tube were misleading.
Easy-to-perform testing procedures as we used here which do not require blood
samples can as a precautious measure ensure that the tubes are used only if they are
of the adequate quality and their quality does not fluctuate too much during the
time. It can alert a laboratory when it would be advisable to perform a much more
complex and time-demanding verification study on blood samples. Archived data
on the tubes’ characteristics and quality during a longer period of time can provide a
piece of evidence for other studies and rule the tubes out as a potential cause for
variations.
2.3 Tubes’ drawing capability reduces during the time
In this section, we explain the changes in a behavior of the tubes during their
shelf life.
The tubes’ drawing capability depends on a difference between the external (pst)
and internal (pint_20°C) pressure. The lower the internal pressure, and the higher the
difference to the external pressure, the higher a drawing capability. A tube’s internal
volume (Vtube) also contributes to higher capacity to draw a liquid.
The tubes of different brands differ in their drawing capability and, in a way,
how it reduces during the time, as Figure 5 demonstrates. No container is entirely
tight and leaks to some extent. The conditions to which the tubes were exposed or
under which they were stored contribute. The tubes of the same lot would behave
differently in different circumstances.
Even though tubes are of a high quality, are purchased at the same time, and
are of the same lot, they are not all the same if used during their shelf life.
Figure 5.
Drawing capability of the tubes reduces continuously during their shelf life.
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A reduction in a drawing capacity results in a diminished draw volume and
enhanced anticoagulant concentration.
The tubes’ validations and verifications with blood samples are essential;
however complex and with no insight into characteristics of the tubes as such, it
is not clear what was actually tested and how representative it is. The outcomes
might vary and can be influenced by a choice of a group of individuals, its
representativeness, a normality of a distribution of the investigated parameter,
and the sources of uncertainty originating from the whole procedure, compris-
ing pre-analytical, analytical, and post-analytical phases. All these factors can
influence the conclusions of a paired t-test or ANOVA, a difference between
two brands, or lots of the tubes might turn out insignificant. Insight into tubes’
characteristics can give the verification and validation studies some basic orien-
tation on what was the status of the tubes that were investigated. If the evalu-
ation is repeated later, one can know how comparable are the examined tubes
entering the process.
If a difference between the results obtained for the tubes of different brands is
confirmed to be statistically significant by the tests performed on blood samples,
they are frequently considered not clinically important. However, variations, which
are not important on the level of a group of individuals, might reflect differently
when a single person is concerned. Personal variations in blood parameters are
narrower than variations on the level of a population. A personal medicine and
athlete’s biological passport require higher sensitivity and attention paid to all
sources of uncertainty.
It is not possible to perform validation study with blood samples for each indi-
vidual, but it is easily possible to perform a quality control of the tubes which are
used for personal profiles.
The athlete’s biological passport (ABP) requires accurate and reliable results of
hematological tests, which are stable enough for evaluations of the probabilities of
abnormalities in a personal profile. Hence, some parameters, e.g., hemoglobin and
erythrocytes, were identified as highly stable; the others such as reticulocytes, mean
red blood cell volume, and hematocrit did not turn out as such. Sample storage
conditions and treatment and the choice of an analyzer are considered the contrib-
uting factors [21].
It was proven that during a training season hemoglobin and hematocrit reduce in
their value, and reticulocytes do as well but independently. The pattern is general
but the size of a change is sport’s discipline dependent. It was recognized that
reliable reference ranges in sportsmen could not be defined without the best labo-
ratory practices [22].
Not univocal and entirely clear outcomes of different studies on the
stability of the blood variables raise concerns and request for more clearly
defined characteristics, procedures, threshold limits, personal reference ranges,
and criteria for recognizing abnormalities to prevent false convictions in
athletes [23].
In order to raise awareness to which extent different pre-analytical phases could
affect the outcomes of hematological and biochemical tests on which sports medi-
cine depends in following athletes, different pre-analytical aspects and the choice of
anticoagulant, instabilities of some molecules were addressed to prevent misinter-
pretation of data and improve the usefulness of results [24]. Specimen homogeni-
zation as a pre-analytical phase received special attention [25].
The variations in tubes’ characteristics did not receive attention in relation to
ABP in spite of the fact that easy-to-perform testing procedures are available [7].
They are thoroughly explained in the continuation.
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3. A methodology for K3EDTA or K2EDTA evacuated blood-collection
tubes’ quality evaluation
A methodology for a quality evaluation of evacuated blood-collection tubes for
hematological tests consists of two successive measurements, a measurement of a
draw volume and electrolytic conductivity, from which one can predict the antico-
agulant concentration in a blood sample. No patient- or person-related samples are
required. A medium for the tests is purified water.
Only low-cost equipment, a Bang burette and a field conductivity meter, is used.
One also needs to know an ambient temperature and a non-reduced pressure for a
period during which measurements were performed. The latter can be obtained
from a local meteorological institution on request, and temperature is easy to mea-
sure. We explain the testing procedures in full details in the following section.
We previously published the nomograms for K2EDTA and K3EDTA tubes with
nominal 3 mL draw volume, which enable a prediction on how is an anticoagulant
concentration going to rise with a diminishing draw volume that happens during
the time because of the aging of the tubes [7].
In Figure 6 we present a nomogram for the K3EDTA tubes with a 2 mL nominal
draw volume relating the electrolytic conductivity, κ, with a predicted anticoagu-
lant concentration, c, and a draw volume, V. The points are the results of the quality
evaluation of the tubes of two different brands, E and G, at the particular moment
in time. If the tubes in a lot are of a homogenous quality and they are going to be
tested later during their shelf life, the anticoagulant concentration as expected for
blood samples is going to rise as the curves indicate. In such a case, a draw-volume
measurement can already give an insight into the quality of the examined tubes.
If we take the G tubes as an example, for the great majority of the tested tubes,
with a draw volume close to 2.1 mL, the anticoagulant concentration anticipated
initially was 4.45 mmol/L. If we assume that later in time we find out that the
draw volume has fallen to 1.9 mL, the anticoagulant concentration for blood
samples is going to be close to 4.95 mmol/L. A green rectangle indicates the limits
set by H1-A5 standard [5], demonstrating that the tubes would still have been of
adequate quality.
Skills needed to perform the tests are not difficult to master, and a laboratory or
medical staff can easily develop them. The quality of the tubes does not deteriorate
very rapidly. It is important to test tubes when they are put into use, and later only
Figure 6.
A nomogram for a prediction on how is the anticoagulant concentration in 2 mL K3EDTA tubes of two different
brands (E, G) going to change with a declining draw volume; green rectangle outlines the characteristics
considered acceptable by H1-A5 standard [5].
9
Pre-Analytical Within-Laboratory Evacuated Blood-Collection Tube Quality Evaluation
DOI: http://dx.doi.org/10.5772/intechopen.80685
occasionally, but at regular intervals. Since the tests are not time-consuming and not
performed in high numbers, this additional workload does not represent an impor-
tant additional burden for personnel; however, the benefits for an institution are
obvious and important.
An institution implementing a quality evaluation scheme always has an adequate
insight into the characteristics and quality of the tubes it is using. It can ensure that
the tubes are used only if and only until they are of adequate quality or it can use the
data in medical and clinical studies to test possible correlations or covariations.
4. Testing procedures
Testing procedures consist of a draw volume and an electrolytic conductivity
measurement (Figure 7 left/right), both later corrected to correspond to a temper-
ature 20°C and an external pressure 101 kPa as required by the standards [5, 6].
4.1 Draw volume
In the schematic (Figure 7), far left, an evacuated tube, characterized by an
internal pressure (pint) and an internal tube volume (Vtube), defining a conserved
energy of withdrawal for a blood specimen collection is depicted.
In the middle, a draw-volume measurement is schematically represented. A
starting point is a Bang burette filled with purified water to the 0 mL mark. A tip of
the burette is attached to a flexible tubing, which is at the other end connected to a
blood-collection device. This part too is entirely filled with purified water. When we
attach an evacuated tube to the venipuncture device, the tube starts filling with
water, and consequently the water level in the Bang burette starts falling. The rising
water level in the tube acts as a moving piston, reducing the void volume and
causing the internal pressure to rise until it equals the external pressure (pext). At
this moment, the withdrawing ends, and we can read the draw volume from a
burette.
Hence, the external pressure and temperature (T) affect a draw-volume test.
The external pressure depends on the altitude and current weather conditions and
can be obtained from the local meteorological institution. The ambient temperature
is also important and has to be taken into account. It affects the internal pressure in
Figure 7.
A setup for a draw-volume measurement (left) and a conductivity cell for the anticoagulant concentration
estimation (right).
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a tube at the instant of the draw-volume measurement. At a higher temperature, the
air in the tube expands, the internal pressure rises, or, in other words, the internal
under-pressure deteriorates, and a tube’s withdrawing ability falls.
For these two reasons, a draw volume (Vdraw) should be corrected to obtain an
estimation of a draw volume, as it would have been, if measured at 1013 hPa and
20°C (Vdraw_st) (1); the symbol K and hPa stand for the units Kelvin and
hectopascal, respectively:
Vdraw_st ¼ Vtube 
pext  293:16 K
T  1013 hPa
Vtube  Vdrawð Þ (1)
The standards [5, 6] admit that if the draw volume under these conditions does
not differ from the nominal volume for more than 10%, the tubes are expected to be
of the adequate quality for a blood specimen collection. For the 3 mL tubes, this
means that the draw volumes between 2.7 and 3.3 mL are acceptable.
Even though the standards [3, 4] expose as the main quality issue in a noncon-
formity of a draw volume with the requirements, our results in Section 2 prove that
a draw volume within the acceptable range does not necessarily ensure the correct
anticoagulant level. An additional insight into this aspect of quality is necessary. For
the K2EDTA and K3EDTA tubes, respectively, a conductance measurement can
provide such an insight.
4.2 Ionic conductivity
K2EDTA and K3EDTA are salts, and salt in water dissociates in ions. Solutions
containing ions conduct electric current, to which extent depends on the ions’
characteristics and their concentration. In other words, conductance (G) of a solu-
tion reflects an overall ionic composition, but, if a solution contains only a single
salt, as it is a case for K2EDTA and K3EDTA tubes, it can provide an insight into a
salt concentration.
A conductance depends on the geometry of a conductivity cell. A cell we used is
depicted in Figure 7 (far right). It was an immersive four-electrode cell, not directly
applicable to our needs. We closed the bottom of the cave with a parafilm and the
hole at the right with a stopper made of a pipette tip to transform it into a conduc-
tivity cell applicable for conductance measurements in solutions of a small volume.
The conductance measurement is affected by a size of electrodes and a distance
between them; a cell geometry is reflected in a cell constant K. If the results of
measurements are expressed as ionic conductivity (κ), they are universally useful
and comparable between different measuring systems (2):
κ ¼ G K (2)
Another concern is a temperature during a measurement; it also affects the
conductance value. At higher temperatures, a conductance is higher. This is taken
into account by reporting an ionic conductivity at a selected reference temperature,
e.g., 20°C. Measurements obtained at an ambient temperature are transformed into
the values as would have been at the reference temperature by taking a temperature
compensation into account. A linear compensation is frequently used; a compensa-
tion factor is usually approximately 2%/°C. In our case, the values confirmed
experimentally were 1.99 or 2.01% for K3EDTA or K2EDTA, respectively.
Conductivity measurements are in fact easy to perform. A conductivity cell has a
temperature sensor incorporated. We select the reference temperature, define a
temperature compensation factor and a cell constant, and perform measurements.
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4.3 Anticoagulant concentration
For a solution of a single salt, electrolytic conductivity values are easy to trans-
form into a salt amount concentration, c. If one prepares a set of the solutions with
the known salt concentrations and determines their electrolytic conductivity at the
reference temperature, one can relate the two parameters by depicting a graph,
with the first parameter on the abscise axis, and the second on the ordinate, defin-
ing a trend line (3):
κ ¼ aþ b c (3)
The symbols, a and b, are the parameter of the linear equation; a stands for the
intercept and b for the slope.
After these two parameters are known, one can measure the electrolytic con-
ductivity of the anticoagulant solution obtained after a draw-volume test to obtain
κV_draw and use the equation in a rearranged form to calculate a concentration of the
anticoagulant, cV_draw (4):
cV_draw ¼
κV_draw  a
b
(4)
This concentration is valid at the draw volume, but one wants to know the
anticoagulant concentration as expected in blood after a specimen collection,
cV_draw_st. As already explained, the draw volume had to be corrected to obtain an
estimation of a blood sample volume; a concentration is volume dependent, and
therefore it has to be corrected too, to correctly represent the anticoagulant con-
centration as expected after a blood specimen collection (5):
cV_draw_st ¼ cV_draw
Vdraw
Vdraw_st
(5)
Draw volume and anticoagulant concentration determination can be
implemented into laboratory quality control routines. If followed during the time in
a form of control charts, they can ensure that the tubes are used only if and only
until they are of adequate quality.
5. Citrate tubes a distinct case
The same testing procedure for a draw-volume measurement is applicable also
to citrate tubes. However, in terms of a determination of the anticoagulant concen-
tration, this is a distinct case. The reason is that citrate in the tubes can be either
buffered or unbuffered. As a result, a solution after a draw-volume test can have
quite a different pH and contains different citrate equilibrium forms in different
proportions. For this reason measurement of electrolytic conductivity cannot be
used here, and an adequate low-cost and easy-to-perform testing procedure yet has
to be developed.
We evaluated the citrate tubes of two different brands, A and B. Both were (1:9)
type tubes but differed in nominal draw volumes, which were 4.5 and 3.6 mL for
tubes A and B, respectively. Measured draw volumes that we obtained were 4.55
and 3.47 mL; it has to be pointed out that these are uncorrected values.
Getting insight into the composition of the anticoagulant solution after a draw-
volume test is possible, but the approach is complex and time-consuming. We used
12
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two ion chromatographic techniques, ion-exclusion chromatography for determi-
nation of citrate and ion-exchange chromatography for determination of cations.
Figure 8 depicts chromatograms obtained for determinations of cations after a
draw-volume test. Four chromatographic peaks emerge. The first peak appearing
between 4 and 6 minutes pertains to the major cation, sodium, originating from the
anticoagulant, trisodium citrate. This peak is presented twice with two different y-
axis scales, in the main chromatogram with its top is out of scale and in the inserted
frame where it is fully visible.
The peak for the A brand tubes is smaller, indicating that in this case citrate is
buffered, while in addition to sodium ions there are hydronium ions (H+, or H3O
+)
to neutralize a negative charge of citrate equilibrium forms. In other words, in the
case of the A brand tubes, the anticoagulant solution was prepared not only from a
trisodium citrate but also with an addition of citric acid. Consequently, the pH of a
solution is lower than with the B brand tubes; the pH results we obtained were 6.1
and 7.9, correspondingly.
As Figure 8 demonstrates, we also confirmed the presence of potassium, a peak
between 6 and 8 minutes; magnesium, a peak at around 10 minutes; and calcium, a
peak at around 12 minutes.
Presence of magnesium came with no surprise; authors using a different analyt-
ical method previously reported on it and explained that it leaks from a closure and
originates from an additive [1]. Though we confirmed a difference between A and B
brand tubes, the latter contained magnesium in much lower concentration.
The concentration of calcium is low in both cases and might be considered an
impurity originating from other chemicals. But what makes a real difference
between the tubes of the two brands and was not expected is potassium. While it is
nearly inexistent in tube B, it is obviously present in tube A. We used infrared
spectroscopy to explain where it originates from; it appears that the source might be
a tripotassium salt of EDTA; if this is the case, its concentration is approximately
200 times lower than the citrate concentration.
6. Conclusions
This research proved differences in characteristics of tubes of different brands
and different lots, and their attributes are also changing during a shelf life. We
suggested fast, easy-to-perform testing procedures, which already by using purified
Figure 8.
Chromatograms for determination of sodium, potassium, magnesium, and calcium in the tubes of two different
brands, A and B, after a draw-volume test.
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water and low-cost equipment only give an insight into draw volume and anticoag-
ulant concentration as can be expected for a blood specimen collection.
No doubt, a laboratory has to prove on blood samples that a particular type of
tubes it is using or intends to use is fit for purpose. But already with a minimum
required number of samples of 20 individuals, a study becomes complex, profes-
sionally demanding, and time-consuming. However, not knowing the characteris-
tics of the tubes entering the investigation lacks generality.
Testing procedures as suggested are not to replace but to support such investi-
gations and to make them more economical. A quality control of the tubes as such is
easy to introduce into a laboratory practice and does not importantly contribute to a
workload. The tubes do not change very rapidly over the time and do not need to be
tested very frequently if of the same lot. However, insight into their characteristics
provides guidance when a study on blood samples needs to step in to cover impor-
tant distinctive conditions a laboratory is likely to face during its everyday routine.
A draw-volume test we described is generally applicable. Procedures for deter-
mining K2EDTA and K3EDTA concentrations in the tubes before a specimen col-
lection are well established; nevertheless comparably easy-to-perform testing
procedures for citrate tubes yet need to be developed.
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